BEYFORTUS (nirsevimab)

**Product type:** Human Prescription Drug

**Active ingredient:** NIRSEVIMAB

**Strength:** 100 mg/mL

**Dosage form:** Injection

**Route:** Intramuscular

**Labeler:** Sanofi Pasteur Inc.

**Marketing category:** BLA (BLA761328)

**Pharmacologic class:** Fusion Protein Inhibitors [MoA], Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]